Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data
ContributorsCooper, Cyrus; Bardin, Thomas; Brandi, Maria-Luisa; Cacoub, Patrice; Caminis, John; Civitelli, Roberto; Cutolo, Maurizio; Dere, Willard; Devogelaer, Jean-Pierre; Diez-Perez, Adolfo; Einhorn, Thomas A.; Emonts, Patrick; Ethgen, Olivier; Kanis, John A.; Kaufman, Jean-Marc; Kvien, Tore K.; Lems, Willem F.; McCloskey, Eugene; Miossec, Pierre; Reiter, Susanne; Ringe, Johann; Rizzoli, René; Saag, Kenneth; Reginster, Jean-Yves
Published inAging Clinical and Experimental Research, vol. 28, no. 1, p. 1-16
Publication date2016
NoteComplément du titre : An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)
Affiliation entities
Research groups
Citation (ISO format)
COOPER, Cyrus et al. Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. In: Aging Clinical and Experimental Research, 2016, vol. 28, n° 1, p. 1–16. doi: 10.1007/s40520-015-0522-1
Main files (1)
Article (Published version)
Identifiers
- PID : unige:81058
- DOI : 10.1007/s40520-015-0522-1
Additional URL for this publicationhttp://link.springer.com/10.1007/s40520-015-0522-1
Journal ISSN1594-0667
